Biomerica (BMRA) Amortization of Deferred Charges (2019 - 2021)

Biomerica has disclosed Amortization of Deferred Charges across 3 years of filings, most recently posting $62897.0 for Q3 2021.

• Amortization of Deferred Charges for Q3 2021 came in at $62897.0, up 9.85% year-over-year; the trailing twelve-month figure through Aug 2021 was $243228.0 (up 8.46% YoY), and the FY2021 annual result was $237588.0, down 11.83% from the prior year.
• Amortization of Deferred Charges came in at $62897.0 for Q3 2021 at Biomerica, down from $63669.0 in the prior quarter.
• In the past five years, Amortization of Deferred Charges ranged from a high of $102456.0 in Q3 2019 to a low of $54900.0 in Q4 2019.
• The 3-year median for Amortization of Deferred Charges is $57768.0 (2020), against an average of $63327.2.
• Across the five-year window, Amortization of Deferred Charges sank 44.12% in 2020 and advanced 12.83% in 2021, its largest moves.
• Biomerica's Amortization of Deferred Charges stood at $54900.0 in 2019, then grew by 5.22% to $57768.0 in 2020, then gained by 8.88% to $62897.0 in 2021.
• The last three Amortization of Deferred Charges figures came in at $62897.0 (Q3 2021), $63669.0 (Q2 2021), and $58894.0 (Q1 2021), per Business Quant data.